Should mannitol be reinstated in prevention of cisplatin-induced nephrotoxicity?

J Oncol Pharm Pract. 2018 Apr;24(3):239-240. doi: 10.1177/1078155216688341. Epub 2017 Feb 5.

Authors

Jean-Philippe Adam^{1

2}, Marie-Andrée Fournier¹, Nathalie Letarte^{1

2

3}

Affiliations

¹ 1 Department of Pharmacy, Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada.
² 2 Centre de Recherche du CHUM, Montréal, QC, Canada.
³ 3 Faculty of Pharmacy, Université de Montréal, Montréal, QC, Canada.

PMID: 28162029
DOI: 10.1177/1078155216688341

No abstract available

Publication types

Comment

MeSH terms

Academic Medical Centers
Cisplatin*
Humans
Inpatients
Kidney Diseases*
Mannitol
Outpatients
Retrospective Studies

Substances

Mannitol
Cisplatin